IMAZIO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 4.156
AS - Asia 2.303
EU - Europa 921
SA - Sud America 499
AF - Africa 57
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.943
Nazione #
US - Stati Uniti d'America 4.011
SG - Singapore 1.083
CN - Cina 449
IT - Italia 409
BR - Brasile 385
VN - Vietnam 218
HK - Hong Kong 171
FR - Francia 109
DE - Germania 106
BD - Bangladesh 97
IN - India 91
CA - Canada 70
RU - Federazione Russa 69
NL - Olanda 49
AR - Argentina 46
KR - Corea 46
FI - Finlandia 32
GB - Regno Unito 28
AT - Austria 25
JP - Giappone 25
EC - Ecuador 24
ID - Indonesia 24
MX - Messico 23
IE - Irlanda 18
ES - Italia 17
TR - Turchia 15
PL - Polonia 14
ZA - Sudafrica 14
JM - Giamaica 13
PY - Paraguay 11
SE - Svezia 11
CL - Cile 10
IQ - Iraq 10
KE - Kenya 10
PK - Pakistan 10
SA - Arabia Saudita 10
CO - Colombia 8
IL - Israele 7
MA - Marocco 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 6
GR - Grecia 6
HN - Honduras 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
JO - Giordania 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
DZ - Algeria 4
MY - Malesia 4
PH - Filippine 4
SV - El Salvador 4
TG - Togo 4
UA - Ucraina 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EG - Egitto 3
KZ - Kazakistan 3
LT - Lituania 3
PE - Perù 3
SN - Senegal 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DM - Dominica 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
TH - Thailandia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MT - Malta 1
Totale 7.934
Città #
Council Bluffs 1.185
San Jose 840
Singapore 511
Ashburn 302
Boardman 292
Hong Kong 166
Beijing 125
Ho Chi Minh City 87
Los Angeles 85
Dallas 74
Santa Clara 72
Pittsburgh 69
Lauterbourg 64
Milan 60
Mumbai 52
Hanoi 49
New York 49
Hefei 47
Seoul 46
Buffalo 40
São Paulo 32
Redondo Beach 31
Frankfurt am Main 29
Rome 29
Chicago 27
Atlanta 26
Munich 24
Helsinki 23
Roubaix 22
Tokyo 21
Amsterdam 20
Vienna 18
Dublin 17
Rio de Janeiro 17
Orem 16
Montreal 15
Nuremberg 15
Remanzacco 15
The Dalles 14
Turin 14
Brooklyn 13
Houston 12
Phoenix 12
Trieste 12
Chennai 11
Denver 11
North Bergen 11
Toronto 11
Chandler 10
Düsseldorf 10
Mexico City 10
Naples 10
Queens 10
Stockholm 10
Udine 10
Bologna 9
Curitiba 9
Da Nang 9
Guayaquil 9
Haiphong 9
Philadelphia 9
Seattle 9
Warsaw 9
Baoding 8
Changsha 8
Johannesburg 8
San Francisco 8
Shenzhen 8
Suzhou 8
Buenos Aires 7
Charlotte 7
Fort Wayne 7
Manchester 7
Quito 7
Shanghai 7
Xi'an 7
Ankara 6
Bari 6
Brasília 6
Figino 6
Kingston 6
Nairobi 6
Porto Alegre 6
Thái Bình 6
Amman 5
Athens 5
Boston 5
Calgary 5
Charlottesville 5
Chengdu 5
Contagem 5
Fortaleza 5
Guarulhos 5
Hyderabad 5
Hải Dương 5
Jacksonville 5
Las Vegas 5
Mauá 5
Memphis 5
Minneapolis 5
Totale 5.100
Nome #
INFLA-score: A new diagnostic paradigm to identify pericarditis 160
Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report 114
Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review 109
Machine-learning tool for classifying pulmonary hypertension via expert reader-provided CT features: An educational resource for non-dedicated radiologists 108
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging 106
Management of cardiac sarcoidosis. A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC 103
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 103
[ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device] 102
Colchicine for the treatment of the spectrum of cardiovascular diseases: Current evidence and ongoing perspectives 100
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 100
Eosinophilic myocarditis: comprehensive update on pathophysiology, diagnosis, prognosis and management 100
New Developments in the Management of Recurrent Pericarditis 97
Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature 96
Asymptomatic Chronic Large Pericardial Effusions: To Drain or to Observe? 95
Colchicine in acute coronary syndromes: the present and the possible future 94
Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study 89
The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases 87
Distal Reoperations after Repair of Acute Type A Aortic Dissection—Incidence, Causes and Outcomes 84
Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis 83
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept 83
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology 80
The 2023 new European guidelines on infective endocarditis: Main novelties and implications for clinical practice 80
Arrhythmic risk in acute myocarditis: Early threats, late events, and clinical uncertainty 78
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases 76
ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes 74
COVID-19 vaccines do not raise myocarditis and pericarditis incidence: Italian Society of Cardiology registry 73
Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene 72
Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin-1 Agents 72
Recurrent pericarditis in older adults: Clinical and laboratory features and outcome 71
Autoptic prevalence of pericarditis in coronavirus disease 2019 patients 71
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 70
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 68
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 67
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases 67
Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion 67
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 66
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 66
How to Use Interleukin-1 Antagonists in Patients With Pericarditis 64
Outcomes of acute pericarditis with an inflammatory phenotype 64
Sudden cardiac death after acute myocarditis with arrhythmic presentation: Hunting for risk predictors - A systematic review and meta-analysis 61
Transthoracic echocardiography for arrhythmic mitral valve prolapse: Phenotypic characterization as first step 61
Advancing our understanding of cardiac tumors 61
Inflammasome and ventricular arrhythmogenesis: Pathogenic interplay and potential targets on the horizon 60
Comparative Efficacy and Safety of Colchicine and Anti–Interleukin- 1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta- Analysis of Randomized Controlled Trials 60
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension 59
Should we start using colchicine for secondary prevention of acute and chronic coronary syndromes after 2024 European society of cardiology guidelines? 57
Focus on 2023 ESC guidelines for the management of infective endocarditis: In light of new evidence 57
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases 56
Unveiling the Spectrum of Pericardial Diseases: Insights, Novelties, and Future Directions 55
Colchicine for prevention of major adverse cardiovascular events: A meta-analysis of randomized clinical trials 54
Risk Stratification of Recurrent Pericarditis: Hype or Hope? 54
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade 54
Prognostic role of genetic variants in recurrent pericarditis 52
Medical therapy of pericarditis: Tips and tricks for clinical practice 52
Beyond the storm: rethinking recovery in fulminant myocarditis 52
When heart team really counts: Radical excision of intracardiac leiomyomatosis 52
Prevention of pericardial complications after cardiac surgery: Myth or reality? 51
Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology 51
Risk of incident pericarditis after coronavirus disease 2019 recovery: a systematic review and meta-analysis 49
One stage extraction and reimplantation of ICD/PM in patients with CIED related endocarditis and spondiloscitis due to E. faecalis treated with double beta-lactam combination: ampicillin plus ceftobiprole 48
Pericardial constrictive syndromes: a neglected cause of reversible heart failure 48
CMR Findings Across Disease Phases in Takotsubo Syndrome: Insights From the Multicenter EVOLUTION Registry 48
Scores for Risk Stratification of Pericarditis 44
Myocarditis: an increasing global health challenge! 38
Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseases 37
Catheter ablation to prevent malignant ventricular arrhythmias in symptomatic Brugada syndrome: A systematic review and meta-analysis 36
Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion 36
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: A report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology 35
On the Road to Disclose the Pathogenesis of Pericarditis 35
Drug-induced pericarditis: a systematic review of all published cases 33
Pericarditis at the crossroads: Unlocking the next wave of therapies 31
Efficacy and safety of colchicine for the treatment of myopericarditis 31
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 29
Dieci quesiti in tema di sarcoidosi cardiaca [Ten questions about cardiac sarcoidosis] 27
Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis 26
Triage and management of acute pericarditis 25
Inflammatory cardiomyopathy: an update for clinicians 25
Coping with recurrent pericarditis: bridging guidelines and clinical practice 25
Resolution of pericardial constriction with anakinra; possible role of C reactive protein 25
The 2025 ESC myocarditis and pericarditis guidelines - what clinicians needs to know 24
Myopericardial Diseases 23
An update on the pathophysiology of acute and recurrent pericarditis 23
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 22
Change in prevalence of ATTR variants in Italy: Results from a national survey 22
Regular Wine Consumption in Chronic Heart Failure: Impact on Outcomes, Quality of Life, and Circulating Biomarkers 21
The top ten novelties of the ESC guidelines for the management of myocarditis and pericarditis 21
Management of myopericarditis 20
Value of pericardial effusion as imaging biomarker in acute pericarditis, do we need to focus on more appropriate ones? 20
Colchicine for acute and chronic coronary syndromes 20
Myocarditis and pericarditis exercise recommendations: a critical review of 2023 COCIS recommendations 20
Inflammatory cardiomyopathy: Position paper of the Italian Society of Cardiology Working Group on cardiomyopathies and pericardial diseases in collaboration with the Italian Society of Cardiology Working Group on cardiac magnetic resonance 19
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series 19
Natriuretic peptides to differentiate constrictive pericarditis and restrictive cardiomyopathy: A systematic review and meta-analysis 18
Evaluation and Treatment of Pericarditis: A Systematic Review 17
Trends in Acute Pericarditis Hospitalizations and Outcomes among the Elderly in the United States, 1999 - 2012 17
Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidence 17
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: When real-life scenarios face the shadows of the evidence-based medicine 17
Prognosis of myopericarditis as determined from previously published reports 16
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists 16
Myocarditis and Pericarditis in Focus: A Brief Report Comparing the 2025 ESC Guidelines and Latest ACC Position Papers 16
Totale 5.557
Categoria #
all - tutte 37.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 1 1
2022/202345 1 0 0 9 7 10 0 3 2 1 9 3
2023/2024134 2 2 33 15 8 7 1 13 7 11 19 16
2024/20251.262 35 67 52 87 67 55 66 73 186 102 219 253
2025/20267.525 244 364 472 447 400 249 254 149 981 1.606 1.509 850
2026/2027493 493 0 0 0 0 0 0 0 0 0 0 0
Totale 9.468